Fulgent Genetics, Inc. SEC filings FLGT
Fulgent Genetics, Inc. has 670 filings in SEC EDGAR's recent list, going back to Jun 9, 2016. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Feb 8, 2024 | — |
| CORRESP | Letter to the SEC | Feb 7, 2024 | — |
| UPLOAD | Letter from the SEC | Jan 30, 2024 | — |
| CORRESP | Letter to the SEC | Jan 9, 2024 | — |
| UPLOAD | Letter from the SEC | Nov 21, 2023 | — |
| CORRESP | Letter to the SEC | Nov 14, 2023 | — |
| UPLOAD | Letter from the SEC | Nov 1, 2023 | — |
| EFFECT | Filing | Aug 12, 2020 | — |
| CORRESP | Letter to the SEC | Aug 7, 2020 | — |
| CORRESP | Letter to the SEC | Aug 5, 2020 | — |
| UPLOAD | Letter from the SEC | Jul 31, 2020 | — |
| EFFECT | Filing | Aug 23, 2019 | — |
| UPLOAD | Letter from the SEC | Aug 22, 2019 | — |
| CORRESP | Letter to the SEC | Aug 21, 2019 | — |
| CT ORDER | Filing | Sep 26, 2017 | — |
| EFFECT | Filing | Sep 28, 2016 | — |
| CORRESP | Letter to the SEC | Sep 28, 2016 | — |
| CORRESP | Letter to the SEC | Sep 28, 2016 | — |
| CERTNAS | Auto-generated paper document | Sep 27, 2016 | — |
| CORRESP | Letter to the SEC | Sep 26, 2016 | — |
| 8-A12B | Form 8-a12b | Sep 26, 2016 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2016 | — |
| CORRESP | Letter to the SEC | Sep 23, 2016 | — |
| CORRESP | Letter to the SEC | Sep 23, 2016 | — |
| CORRESP | Letter to the SEC | Sep 8, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 29, 2016 | — |
| DRS/A | Filing | Aug 18, 2016 | — |
| UPLOAD | Letter from the SEC | Aug 1, 2016 | — |
| DRS/A | Filing | Jul 15, 2016 | — |
| UPLOAD | Letter from the SEC | Jul 7, 2016 | — |
| DRS | Filing | Jun 9, 2016 | — |
Showing 31 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Services-Medical Laboratories (SIC 8071)
- Listed as
- FLGT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- El Monte, CA
- SEC filer status
- Accelerated filer
- SEC CIK
- 1674930
- Former names
- Fulgent Diagnostics, Inc. (until Jul 15, 2016)
Other Services-Medical Laboratories companies
- Natera, Inc. NTRA
- Labcorp Holdings Inc. LH
- Quest Diagnostics Inc DGX
- Guardant Health, Inc. GH
- Caris Life Sciences, Inc. CAI
- GRAIL, Inc. GRAL
- RadNet, Inc. RDNT
- BillionToOne, Inc. BLLN
Source: SEC EDGAR filings. This is company-reported data, not investment advice.